Dennis Langer Myriad Genetics Inc (MYGN) insider trading activity

MYGN Quotes by TradingView

Dennis Langer is Director of MYRIAD GENETICS INC. Currently has a direct ownership of 106,802 shares of MYGN, which is worth approximately $1.65 Million. The most recent transaction as insider was on Jun 02, 2022, when has been sold 17,275 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 107K
0% 3M change
0% 12M change
Total Value Held $1.65 Million

DENNIS LANGER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2022
BUY
Grant, award, or other acquisition
-
17,275 Added 13.92%
106,802 Common Stock
Aug 03 2021
SELL
Open market or private sale
$1,042,500 $34.75 p/Share
30,000 Reduced 25.1%
89,527 Common Stock
Aug 03 2021
BUY
Exercise of conversion of derivative security
$761,700 $25.39 p/Share
30,000 Added 20.06%
119,527 Common Stock
Jun 03 2021
BUY
Grant, award, or other acquisition
-
12,848 Added 12.55%
89,527 Common Stock
Dec 04 2020
BUY
Grant, award, or other acquisition
-
15,889 Added 17.16%
76,679 Common Stock

Also insider at

BTX
Brooklyn ImmunoTherapeutics, Inc. Healthcare
QNRX
Quoin Pharmaceuticals, Ltd. Healthcare
Director
DL

Dennis Langer

Director
Salt Lake City, UT

Track Institutional and Insider Activities on MYGN

Follow MYRIAD GENETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

News

Receive news related to MYRIAD GENETICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MYGN